🧬eMalick Njie, Ph.D - Ecotone - Part 4 | Building Ecotone AI to Cure Rare Diseases | Diffusion Transformers in Genomics | Synthetic Genomes for AI Training | Long-Term Vision for Genetic Breakthroughs

episode

The Biotech Startups Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Hog Heaven, MAGA Hell 52 min · 24 Sep 2026 · I've Had It

KFC and Gen Z, OAPs and ChatGPT & An Email to Jimmy Fallon. 34 min · 24 Sep 2026 · Ray D'Arcy Daily

Bonds, Stocks Drop as Yields Extend Rally 2 min · 24 Sep 2026 · WSJ Minute Briefing

Judge gives press a pass 4 min · 24 Sep 2026 · Wall Street Breakfast

Court Temporarily Blocks Media Ban, Trump-Xi White House Meeting, UNGA Diplomacy 15 min · 24 Sep 2026 · Up First from NPR

NPR News: 09-24-2026 6AM EDT 5 min · 24 Sep 2026 · NPR News Now

Report any issue

Source

Recorded17 Oct 2024

Publisherfeeds.fame.so ↗

Handlerec:3386495

Show notes

Jon Chee hosts our latest guest, eMalick Njie, CEO of Ecotone AI, a healthcare company that is using AI to find cures for inherited diseases. eMalick is an experienced scientist and entrepreneur who has focused on blending his expertise in neuroscience with his knowledge of AI. In addition to founding two AI companies, Ecotone and Genetic Intelligence, eMalick received his PhD in Neurobiology and Neuroscience from the University of Florida. His extensive and diverse experience from being a postdoctoral fellow at Columbia university to being the CEO of the AI thinktank NeuroStorm makes our conversation with him one you won’t want to miss.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in